To test whether Dtx3L/Parp9 contributes to AR-regulated gene expression in prostate cancer cells, we engineered VCaP cells with a Dox-inducible shRNA to Dtx3L (Supplementary Fig. 22a) and used the lines for transcriptomic analysis. The gene discussed is AR; the disease is prostate carcinoma.